Ketotifen Stulln 0,25 Mg/Ml Augentropfen Pharma Stulln

Ketotifen, the active ingredient in Ketotifen Stulln 0,25 Mg/mL Augentropfen Pharma Stulln, is an antihistamine (mast cell stabilizer) presented as a 0.25 mg/mL eye‑drop solution for ocular use. It is indicated for the relief of allergic conjunctivitis, ocular itching, redness and irritation caused by allergic reactions.

GNH USA supplies Ketotifen Stulln 0,25 Mg/mL Augentropfen Pharma Stulln as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing reliable access to this ophthalmic preparation.

Ketotifen is used to manage allergic eye conditions by stabilizing mast cells and blocking histamine.

Allergic conjunctivitis: reduces redness, itching and swelling in the conjunctiva. Seasonal allergic eye disease: alleviates ocular itching and tearing during pollen seasons. Allergic keratoconjunctivitis: controls inflammation and discomfort of the cornea and conjunctiva.

Ketotifen eye drops may cause local ocular reactions and, rarely, systemic hypersensitivity.

Common Side Effects: - Stinging or burning sensation upon instillation. - Transient blurred vision. - Mild eye irritation or redness. - Headache. - Dry eye sensation. - Temporary conjunctival hyperemia.

Serious or Rare Side Effects: - Severe allergic reaction (e.g., angio‑edema, anaphylaxis). - Persistent or worsening blurred vision. - Corneal ulceration or severe eye inflammation. - Significant ocular pain requiring medical attention.

Before using Ketotifen eye drops, consider the following precautions.

Pregnancy: safety not established; use only if clearly needed. Breastfeeding: unknown safety; consult a healthcare professional. Contact lens wearers: remove lenses before instillation and wait before reinserting. Active ocular infection: avoid use until infection is resolved. Concurrent systemic antihistamines: may increase ocular dryness. Store at room temperature: keep in original container, protect from light and moisture.

Ketotifen may interact with other ophthalmic or systemic agents.

Major Interactions (Avoid): - Systemic antihistamines: may potentiate ocular dryness. - MAO inhibitors: theoretical risk of enhanced histamine blockade.

Moderate Interactions (Monitor Closely): - Topical ophthalmic anesthetics: may increase irritation. - Other mast cell stabilizers: additive effect on ocular tissues. - Contact lens solutions: may alter drug stability or cause irritation.